Published in Eur Spine J on February 19, 2014
Reviewer's comment concerning "Is NICE guidance for identifying lumbar nerve root compression misguided?" (doi:10.1007/s00586-014-3233-y by T. Germon et al.). Eur Spine J (2014) 0.75
A valid model for predicting responsible nerve roots in lumbar degenerative disease with diagnostic doubt. BMC Musculoskelet Disord (2016) 0.75
Lumbar disc herniation. A controlled, prospective study with ten years of observation. Spine (Phila Pa 1976) (1983) 5.72
The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. J Spinal Disord (2000) 4.41
Surgery for low back pain: a review of the evidence for an American Pain Society Clinical Practice Guideline. Spine (Phila Pa 1976) (2009) 3.80
Surgical versus nonoperative treatment for lumbar disc herniation: four-year results for the Spine Patient Outcomes Research Trial (SPORT). Spine (Phila Pa 1976) (2008) 3.46
Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976) (2005) 3.17
Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol (2007) 2.53
Sciatica: review of epidemiological studies and prevalence estimates. Spine (Phila Pa 1976) (2008) 2.09
Lack of effectiveness of bed rest for sciatica. N Engl J Med (1999) 1.82
Surgical interventions for lumbar disc prolapse. Cochrane Database Syst Rev (2007) 1.38
Normality and reliability in the clinical assessment of backache. Br Med J (Clin Res Ed) (1982) 1.24
Measuring outcomes in cervical spine surgery: think twice before using the SF-36. Spine (Phila Pa 1976) (2006) 1.11
The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model. Health Technol Assess (2011) 1.07
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Measuring outcomes in cervical spine surgery: think twice before using the SF-36. Spine (Phila Pa 1976) (2006) 1.11
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. Lancet Neurol (2006) 0.99
Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol (2002) 0.98
Measuring health-related quality of life in MSA: the MSA-QoL. Mov Disord (2007) 0.91
Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease. J Neurol (2011) 0.91
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures. Mult Scler (2013) 0.80
Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach. Alzheimers Dement (2013) 0.78
Measuring outcomes in clinical trials of stroke: time for state-of-the-art clinical trials to reject state-of-the-ark rating scales. J Neurol (2007) 0.77
Exploring the relationships between provision of welfare benefits advice and the health of elderly people: a longitudinal observational study and discussion of methodological issues. Health Soc Care Community (2007) 0.77